-
-
-
-
-
-
-
Medifast Announces Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
LifeMD Reports Third Quarter 2024 Results
-
-
-
-
-
-
-
Medifast (MED) Initiates Business Transformation, Enters Medically Supported Weight Loss Market through Collaboration with LifeMD (LFMD)
-
-
-
-
-
-
-
LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDA
-
-
-
-
-
-
-
LifeMD Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues
-
-
-
-
-
-
-
LifeMD (LFMD) Prices 3.33M Share Offering of Common Stock at $6/Each
-
-
-
-
-
-
-
LifeMD Reports Q2 2021 Revenue Up 145% to Record $22.3 Million, Driven by Reduced Acquisition Costs and Strong Retention
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

